Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.

Hoffmann C, Amiral J, Rezig S, Kerspern H, Jantzem H, Robin S, Collins A, Mornet C, Mingant F, Pan Petesch B, Ianotto JC, Lippert E, Galinat H.

Eur J Haematol. 2019 Aug;103(2):137-139. doi: 10.1111/ejh.13249. Epub 2019 May 28.

PMID:
31102471
2.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

3.

Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.

Desjonqueres A, Guillet B, Beurrier P, Pan-Petesch B, Ardillon L, Pineau-Vincent F, Sigaud M, Fouassier M, Ternisien C, Gillet B, Béné MC, Horvais V, Lienhart A, Trossaërt M.

Br J Haematol. 2019 May;185(4):764-767. doi: 10.1111/bjh.15606. Epub 2018 Oct 18. No abstract available.

PMID:
30338508
4.

[Risk factors for thromboembolic disease in young women-the role of hormones].

Tromeur C, Le Mao R, Jego P, El-Kouri D, Gruel Y, Pan-Petesch B, Bertoletti L, Morange PE, Lemoigne E, Paleiron N, Leroyer C, Couturaud F.

Rev Mal Respir. 2019 Feb;36(2):219-226. doi: 10.1016/j.rmr.2018.05.013. Epub 2018 Oct 11. French.

PMID:
30318429
5.

Generalized pustular psoriasis as an unusual cause of acquired haemophilia A.

Le Bris V, Pan-Petesch B, Guillerm G, Misery L, Brenaut E.

Eur J Dermatol. 2018 Jun 1;28(3):417-418. doi: 10.1684/ejd.2018.3271. No abstract available.

PMID:
30105997
6.

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study.

Resseguier N, Rosso-Delsemme N, Beltran Anzola A, Baumstarck K, Milien V, Ardillon L, Bayart S, Berger C, Bertrand MA, Biron-Andreani C, Borel-Derlon A, Castet S, Chamouni P, Claeyssens Donadel S, De Raucourt E, Desprez D, Falaise C, Frotscher B, Gay V, Goudemand J, Gruel Y, Guillet B, Harroche A, Hassoun A, Huguenin Y, Lambert T, Lebreton A, Lienhart A, Martin M, Meunier S, Monpoux F, Mourey G, Negrier C, Nguyen P, Nyombe P, Oudot C, Pan-Petesch B, Polack B, Rafowicz A, Rauch A, Rivaud D, Schneider P, Spiegel A, Stoven C, Tardy B, Trossaërt M, Valentin JB, Vanderbecken S, Volot F, Voyer-Ebrard A, Wibaut B, Leroy T, Sannie T, Chambost H, Auquier P.

BMJ Open. 2018 Jul 25;8(7):e022409. doi: 10.1136/bmjopen-2018-022409.

7.

[Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?]

de Moreuil C, Fauchais AL, Merviel P, Tremouilhac C, Le Moigne E, Pasquier E, Pan-Petesch B, Lacut K.

Rev Med Interne. 2018 Dec;39(12):935-941. doi: 10.1016/j.revmed.2018.06.001. Epub 2018 Jun 20. Review. French.

PMID:
29933972
8.

Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms.

Delluc A, Lacut K, Pan-Petesch B, Galinat H, Lippert E, Ianotto JC.

Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16. No abstract available.

PMID:
29787944
9.

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.

Mollard LM, Le Mao R, Tromeur C, Le Moigne E, Gouillou M, Pan-Petesch B, Delluc A, Couturaud F, Lacut K.

Eur J Intern Med. 2018 Jun;52:22-27. doi: 10.1016/j.ejim.2018.02.030. Epub 2018 Mar 13.

PMID:
29548526
10.

Erasmus syndrome associated with an immune thrombocytopenic purpura.

Fouchard M, Pan Petesch B, Abasq-Thomas C, Saraux A, Misery L, Brenaut E.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e261-e262. doi: 10.1111/jdv.14785. Epub 2018 Jan 24. No abstract available.

PMID:
29314277
11.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

12.

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B; Group for the PGRx-ITP Study.

Haematologica. 2016 Sep;101(9):1039-45. doi: 10.3324/haematol.2016.146373. Epub 2016 May 26.

13.

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

Santagostino E, Martinowitz U, Lissitchkov T, Pan-Petesch B, Hanabusa H, Oldenburg J, Boggio L, Negrier C, Pabinger I, von Depka Prondzinski M, Altisent C, Castaman G, Yamamoto K, Álvarez-Roman MT, Voigt C, Blackman N, Jacobs I; PROLONG-9FP Investigators Study Group.

Blood. 2016 Apr 7;127(14):1761-9. doi: 10.1182/blood-2015-09-669234. Epub 2016 Jan 11.

14.

A missense mutation in the alpha-actinin 1 gene (ACTN1) is the cause of autosomal dominant macrothrombocytopenia in a large French family.

Guéguen P, Rouault K, Chen JM, Raguénès O, Fichou Y, Hardy E, Gobin E, Pan-Petesch B, Kerbiriou M, Trouvé P, Marcorelles P, Abgrall JF, Le Maréchal C, Férec C.

PLoS One. 2013 Sep 17;8(9):e74728. doi: 10.1371/journal.pone.0074728. eCollection 2013.

15.

Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.

Ngo Sack F, Galinat H, Egreteau PY, Mollard LM, Fortin H, Berthou C, Abgrall JF, Pan-Petesch B.

Haemophilia. 2013 Mar;19(2):e93-4. doi: 10.1111/hae.12069. Epub 2012 Dec 4. No abstract available.

PMID:
23205641
16.

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

Grimaldi-Bensouda L, Michel M, Aubrun E, Leighton P, Viallard JF, Adoue D, Magy-Bertrand N, Tisserand G, Khellaf M, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Limal N, Costedoat-Chalumeau N, Morel N, Pan-Petesch B, Decaux O, Mahevas M, Ruel M, Sacre K, Lefrere F, Abenhaim L, Godeau B; PGRx Immune Thrombocytopenia Study Group.

Blood. 2012 Dec 13;120(25):4938-44. doi: 10.1182/blood-2012-05-431098. Epub 2012 Oct 24.

17.

Revisiting the molecular epidemiology of factor XI deficiency: nine new mutations and an original large 4qTer deletion in western Brittany (France).

Guéguen P, Chauvin A, Quémener-Redon S, Pan-Petesch B, Férec C, Abgrall JF, Le Maréchal C.

Thromb Haemost. 2012 Jan;107(1):44-50. doi: 10.1160/TH11-06-0415. Epub 2011 Dec 8.

18.

Biological determinants of bleeding in patients with heterozygous factor XI deficiency.

Guéguen P, Galinat H, Blouch MT, Bridey F, Duchemin J, Le Gal G, Abgrall JF, Pan-Petesch B.

Br J Haematol. 2012 Jan;156(2):245-51. doi: 10.1111/j.1365-2141.2011.08945.x. Epub 2011 Nov 21.

PMID:
22098495
19.

Tears of blood?

Rouxel AM, Roguedas AM, Roussel B, Bettembourg S, Richard Y, Pan-Petesch B, De Parscau L, Lazartigues A, Misery L.

Eur J Dermatol. 2010 Mar-Apr;20(2):232-3. doi: 10.1684/ejd.2010.0866. Epub 2010 Jan 14. No abstract available.

PMID:
20071303
20.

Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.

Pan-Petesch B, Laguna P, Mital A, Stanley J, Torchet MF, Salek SZ, Salaj P.

Haemophilia. 2009 May;15(3):760-5. doi: 10.1111/j.1365-2516.2008.01968.x. Epub 2009 Feb 27.

PMID:
19298382
21.

Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.

Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF.

Thromb Haemost. 2008 Apr;99(4):767-73. doi: 10.1160/TH07-09-0581.

PMID:
18392335

Supplemental Content

Loading ...
Support Center